Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 337

1.

NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.

Sun Z, Tong G, Ma N, Li J, Li X, Li S, Zhou J, Xiong L, Cao F, Yao L, Wang H, Shen L.

Basic Res Cardiol. 2013;108(3):341. doi: 10.1007/s00395-013-0341-5. Epub 2013 Mar 6.

PMID:
23463182
[PubMed - indexed for MEDLINE]
2.

Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.

Huang C, Cui Y, Ji L, Zhang W, Li R, Ma L, Xing W, Zhou H, Chen B, Yu J, Zhang H.

Pharm Biol. 2013 Apr;51(4):463-73. doi: 10.3109/13880209.2012.740052. Epub 2013 Jan 22.

PMID:
23336403
[PubMed - indexed for MEDLINE]
3.

Cardioprotection induced by hydrogen sulfide preconditioning involves activation of ERK and PI3K/Akt pathways.

Hu Y, Chen X, Pan TT, Neo KL, Lee SW, Khin ES, Moore PK, Bian JS.

Pflugers Arch. 2008 Jan;455(4):607-16. Epub 2007 Aug 1.

PMID:
17674030
[PubMed - indexed for MEDLINE]
4.

Survivin: a novel player in insulin cardioprotection against myocardial ischemia/reperfusion injury.

Si R, Tao L, Zhang HF, Yu QJ, Zhang R, Lv AL, Zhou N, Cao F, Guo WY, Ren J, Wang HC, Gao F.

J Mol Cell Cardiol. 2011 Jan;50(1):16-24. doi: 10.1016/j.yjmcc.2010.08.017. Epub 2010 Aug 27.

PMID:
20801129
[PubMed - indexed for MEDLINE]
5.

Panax notoginseng saponins inhibit ischemia-induced apoptosis by activating PI3K/Akt pathway in cardiomyocytes.

Chen S, Liu J, Liu X, Fu Y, Zhang M, Lin Q, Zhu J, Mai L, Shan Z, Yu X, Yang M, Lin S.

J Ethnopharmacol. 2011 Sep 1;137(1):263-70. doi: 10.1016/j.jep.2011.05.011. Epub 2011 May 17.

PMID:
21619920
[PubMed - indexed for MEDLINE]
6.

Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.

Hamid SA, Bower HS, Baxter GF.

Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H2598-606. Epub 2007 Jan 12.

PMID:
17220176
[PubMed - indexed for MEDLINE]
Free Article
7.

TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.

Ha T, Hu Y, Liu L, Lu C, McMullen JR, Kelley J, Kao RL, Williams DL, Gao X, Li C.

Cardiovasc Res. 2010 Sep 1;87(4):694-703. doi: 10.1093/cvr/cvq116. Epub 2010 Apr 26.

PMID:
20421349
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.

Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE.

Basic Res Cardiol. 2007 Jul;102(4):350-8. Epub 2007 Apr 30.

PMID:
17468933
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression.

Bhuiyan MS, Shibuya M, Shioda N, Moriguchi S, Kasahara J, Iwabuchi Y, Fukunaga K.

Eur J Pharmacol. 2007 Oct 1;571(2-3):180-8. Epub 2007 Jun 9.

PMID:
17658509
[PubMed - indexed for MEDLINE]
10.

α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway.

Deng C, Sun Z, Tong G, Yi W, Ma L, Zhao B, Cheng L, Zhang J, Cao F, Yi D.

PLoS One. 2013;8(3):e58371. doi: 10.1371/journal.pone.0058371. Epub 2013 Mar 7.

PMID:
23505496
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats.

Deschamps AM, Murphy E.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1806-13. doi: 10.1152/ajpheart.00283.2009. Epub 2009 Aug 28.

PMID:
19717735
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes.

Alloatti G, Arnoletti E, Bassino E, Penna C, Perrelli MG, Ghé C, Muccioli G.

Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H470-81. doi: 10.1152/ajpheart.00800.2009. Epub 2010 Jun 4.

PMID:
20525876
[PubMed - indexed for MEDLINE]
Free Article
13.

The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.

Duan W, Yang Y, Yan J, Yu S, Liu J, Zhou J, Zhang J, Jin Z, Yi D.

Basic Res Cardiol. 2012;107(3):263. doi: 10.1007/s00395-012-0263-7. Epub 2012 Mar 31.

PMID:
22466958
[PubMed - indexed for MEDLINE]
14.

Myocardial reperfusion injury management: erythropoietin compared with postconditioning.

Tamareille S, Ghaboura N, Treguer F, Khachman D, Croué A, Henrion D, Furber A, Prunier F.

Am J Physiol Heart Circ Physiol. 2009 Dec;297(6):H2035-43. doi: 10.1152/ajpheart.00472.2009. Epub 2009 Jul 17. Erratum in: Am J Physiol Heart Circ Physiol. 2009 Dec;297:H2035.

PMID:
19617412
[PubMed - indexed for MEDLINE]
Free Article
15.

Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice.

Morrison A, Yan X, Tong C, Li J.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H895-902. doi: 10.1152/ajpheart.00137.2011. Epub 2011 Jun 10.

PMID:
21666107
[PubMed - indexed for MEDLINE]
Free Article
16.

Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.

Zhang T, Li Z, Dang H, Chen R, Liaw C, Tran TA, Boatman PD, Connolly DT, Adams JW.

Am J Physiol Heart Circ Physiol. 2012 Jan 1;302(1):H299-311. doi: 10.1152/ajpheart.00723.2011. Epub 2011 Oct 14.

PMID:
22003054
[PubMed - indexed for MEDLINE]
Free Article
17.

Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.

Obana M, Miyamoto K, Murasawa S, Iwakura T, Hayama A, Yamashita T, Shiragaki M, Kumagai S, Miyawaki A, Takewaki K, Matsumiya G, Maeda M, Yoshiyama M, Nakayama H, Fujio Y.

Am J Physiol Heart Circ Physiol. 2012 Sep 1;303(5):H569-77. doi: 10.1152/ajpheart.00060.2012. Epub 2012 Jun 15.

PMID:
22707562
[PubMed - indexed for MEDLINE]
Free Article
18.

PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.

Bulhak AA, Jung C, Ostenson CG, Lundberg JO, Sjöquist PO, Pernow J.

Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H719-27. doi: 10.1152/ajpheart.00394.2008. Epub 2009 Jan 16.

PMID:
19151258
[PubMed - indexed for MEDLINE]
Free Article
19.

Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.

Jeong CW, Yoo KY, Lee SH, Jeong HJ, Lee CS, Kim SJ.

J Cardiovasc Pharmacol Ther. 2012 Dec;17(4):387-94. doi: 10.1177/1074248412438102. Epub 2012 Mar 6.

PMID:
22396328
[PubMed - indexed for MEDLINE]
20.

PPAR-alpha activation as a preconditioning-like intervention in rats in vivo confers myocardial protection against acute ischaemia-reperfusion injury: involvement of PI3K-Akt.

Ravingerová T, Carnická S, Nemčeková M, Ledvényiová V, Adameová A, Kelly T, Barlaka E, Galatou E, Khandelwal VK, Lazou A.

Can J Physiol Pharmacol. 2012 Aug;90(8):1135-44. doi: 10.1139/y2012-052. Epub 2012 Jul 18.

PMID:
22809038
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk